Literature DB >> 20434495

A multiplex PCR method to detect 14 Escherichia coli serogroups associated with urinary tract infections.

Dan Li1, Bin Liu, Min Chen, Dan Guo, Xi Guo, Fenxia Liu, Lu Feng, Lei Wang.   

Abstract

Urinary tract infections (UTIs) are one of the most common bacterial infections and are predominantly caused by uropathogenic Escherichia coli (UPEC). E. coli strains belonging to 14 serogroups, including O1, O2, O4, O6, O7, O8, O15, O16, O18, O21, O22, O25, O75 and O83, are the most frequently detected UPEC strains in a diverse range of clinical urine specimens. In the current study, the O-antigen gene clusters of E. coli serogroups O1, O2, O18 and O75 were characterized. A multiplex PCR method based on O-antigen-specific genes was developed for the simultaneous detection of all 14 E. coli serogroups. The multiplex PCR method was shown to be highly specific and reproducible when tested against 186 E. coli and Shigella O-serogroup reference strains, 47 E. coli clinical isolates and 10 strains of other bacterial species. The sensitivity of the multiplex PCR method was analyzed and shown to detect O-antigen-specific genes in samples containing 25 ng of genomic DNA or in mock urine specimens containing 40 colony-forming units (CFUs) per ml. Five urine specimens from hospital were examined using this multiplex PCR method, and the result for one sample was verified by the conventional serotyping methods. The multiplex PCR method developed herein can be used for the detection of relevant E. coli strains from clinical and/or environmental samples, and it is particularly useful for epidemiologic analysis of urine specimens from patients with UTIs. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434495     DOI: 10.1016/j.mimet.2010.04.008

Source DB:  PubMed          Journal:  J Microbiol Methods        ISSN: 0167-7012            Impact factor:   2.363


  36 in total

1.  Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.

Authors:  Dennis J Horvath; Ashay S Patel; Ahmad Mohamed; Douglas W Storm; Chandra Singh; Birong Li; Jingwen Zhang; Stephen A Koff; Venkata R Jayanthi; Kevin M Mason; Sheryl S Justice
Journal:  J Bacteriol       Date:  2016-01-11       Impact factor: 3.490

2.  Serotypes, virulence factors, and antimicrobial susceptibilities of vaginal and fecal isolates of Escherichia coli from giant pandas.

Authors:  Xin Wang; Qigui Yan; Xiaodong Xia; Yanming Zhang; Desheng Li; Chengdong Wang; Shijie Chen; Rong Hou
Journal:  Appl Environ Microbiol       Date:  2013-06-21       Impact factor: 4.792

3.  Characterization of globally spread Escherichia coli ST131 isolates (1991 to 2010).

Authors:  Angela Novais; João Pires; Helena Ferreira; Luísa Costa; Carolina Montenegro; Claudia Vuotto; Gianfranco Donelli; Teresa M Coque; Luísa Peixe
Journal:  Antimicrob Agents Chemother       Date:  2012-04-09       Impact factor: 5.191

4.  Pathogenic potential of Escherichia coli clinical strains from orthopedic implant infections towards human osteoblastic cells.

Authors:  Lise Crémet; Alexis Broquet; Bénédicte Brulin; Cédric Jacqueline; Sandie Dauvergne; Régis Brion; Karim Asehnoune; Stéphane Corvec; Dominique Heymann; Nathalie Caroff
Journal:  Pathog Dis       Date:  2015-09-01       Impact factor: 3.166

5.  Phylogenetic Analysis of Enteroaggregative Escherichia coli (EAEC) Isolates from Japan Reveals Emergence of CTX-M-14-Producing EAEC O25:H4 Clones Related to Sequence Type 131.

Authors:  Naoko Imuta; Tadasuke Ooka; Kazuko Seto; Ryuji Kawahara; Toyoyasu Koriyama; Tsuyoshi Kojyo; Atsushi Iguchi; Koichi Tokuda; Hideki Kawamura; Kiyotaka Yoshiie; Yoshitoshi Ogura; Tetsuya Hayashi; Junichiro Nishi
Journal:  J Clin Microbiol       Date:  2016-06-01       Impact factor: 5.948

6.  Development and Qualification of an Opsonophagocytic Killing Assay To Assess Immunogenicity of a Bioconjugated Escherichia coli Vaccine.

Authors:  Darren Abbanat; Todd A Davies; Karen Amsler; Wenping He; Kellen Fae; Sarah Janssen; Jan T Poolman; Germie P J M van den Dobbelsteen
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

7.  Uropathogenic Escherichia coli in Iran: serogroup distributions, virulence factors and antimicrobial resistance properties.

Authors:  Hassan Momtaz; Azam Karimian; Mahboobeh Madani; Farhad Safarpoor Dehkordi; Reza Ranjbar; Meysam Sarshar; Negar Souod
Journal:  Ann Clin Microbiol Antimicrob       Date:  2013-04-29       Impact factor: 3.944

8.  |Isolation and characterization of novel bacteriophages as a potential therapeutic option for Escherichia coli urinary tract infections.

Authors:  Edgar González-Villalobos; Rosa María Ribas-Aparicio; Gerardo Erbey Rodea Montealegre; Laura Belmont-Monroy; Yerisaidy Ortega-García; Gerardo Aparicio-Ozores; José Luis Balcázar; Carlos Alberto Eslava-Campos; Ulises Hernández-Chiñas; José Molina-López
Journal:  Appl Microbiol Biotechnol       Date:  2021-07-12       Impact factor: 4.813

9.  Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli.

Authors:  Dorota Wojnicz; Alicja Z Kucharska; Anna Sokół-Łętowska; Marta Kicia; Dorota Tichaczek-Goska
Journal:  Urol Res       Date:  2012-08-23

10.  Green tea as an effective antimicrobial for urinary tract infections caused by Escherichia coli.

Authors:  Wanda Reygaert; Ilir Jusufi
Journal:  Front Microbiol       Date:  2013-06-18       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.